New ELISA Kits using C3 Binding Glycoprotein from Cuscuta europea Detect Mainly IgM CIC in Rheumatoid Arthritis and Progressive Systemic Sclerosis, but not in Systemic Lupus Erythematosus
2003

New ELISA Kits for Detecting Immune Complexes in Autoimmune Diseases

Sample size: 214 publication 10 minutes Evidence: moderate

Author Information

Author(s): SPASKA ANGELOVA STANILOVA, EMIL SLAVOV SLAVOV

Primary Institution: Department of Molecular Biology and Immunology, Medical Faculty, Thracian University

Hypothesis

The study aims to evaluate the effectiveness of new ELISA kits in detecting different immunoglobulin isotypes in circulating immune complexes (CIC) in patients with autoimmune diseases.

Conclusion

The new CIF-ELISA method shows higher sensitivity for detecting IgM-CIC in rheumatoid arthritis and progressive systemic sclerosis compared to the traditional ANTI-C3 ELISA.

Supporting Evidence

  • The sensitivity of CIF-ELISA for IgM-CIC was 40.0% in RA patients compared to 20.95% for ANTI-C3 ELISA.
  • CIF-ELISA showed higher sensitivity for IgM-CIC in progressive systemic sclerosis compared to ANTI-C3 ELISA.
  • Concordance of IgM-CIC positives was 48.84% in RA and 46.67% in PSS.
  • Statistically significant differences were found between control and patient groups for both methods used.

Takeaway

Researchers created new tests to find specific types of antibodies in the blood of people with certain diseases, helping doctors understand these diseases better.

Methodology

The study used two ELISA methods, CIF-ELISA and ANTI-C3 ELISA, to assess levels of IgM-CIC, IgG-CIC, and IgA-CIC in serum samples from patients with rheumatoid arthritis, systemic lupus erythematosus, and progressive systemic sclerosis.

Potential Biases

Potential bias may arise from the selection of patient samples and the methods used for serum collection and analysis.

Limitations

The study may not account for all variables affecting immune complex levels, and the sample size may limit the generalizability of the findings.

Participant Demographics

The study included 214 participants: 99 with rheumatoid arthritis, 88 with systemic lupus erythematosus, 27 with progressive systemic sclerosis, and 55 healthy controls.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1080/10446670310001626544

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication